Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Proteome Research

• Publication date

  2006-08-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/PR060235VPMID 17022645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.

  2005cited by this paper
• Effect of immunoaffinity depletion of human serum during proteomic investigations.

  2005cited by this paper
• Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype.

  2005cited by this paper
• Thymic Recovery among Pediatric Stem Cell Recipients.

  2005cited by this paper
• Therapy for colorectal cancer.

  2005cited by this paper
• Nucleophosmin in acute myelogenous leukemia.

  2005cited by this paper
• When epigenetics kills: MLL fusion proteins in leukemia

  2005cited by this paper
• New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes

  2005cited by this paper
• Therapy for colorectal cancer.

  2005cited by this paper
• NPM mutations in acute myelogenous leukemia.

  2005cited by this paper
• Analysis of protein expression during oxidative stress in breast epithelial cells using a stable isotope labeled proteome internal standard.

  2005cited by this paper
• Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness

  2004cited by this paper
• Recent advances in early-onset severe retinal degeneration: more than just basic research.

  2004cited by this paper
• Altered states: selectively drugging the Hsp90 cancer chaperone.

  2004cited by this paper
• Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements.

  2003cited by this paper
• MLL-mediated transcriptional gene regulation investigated by gene expression profiling

  2003cited by this paper
• Molecular characterization of acute leukemias by use of microarray technology

  2003cited by this paper
• FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases.

  2003cited by this paper
• Gene expression profiling as a tool for the diagnosis of acute leukemias.

  2003cited by this paper
• A novel experimental design for comparative two‐dimensional gel analysis: Two‐dimensional difference gel electrophoresis incorporating a pooled internal standard

  2003cited by this paper
• MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

  2002cited by this paper
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

  2002cited by this paper
• Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics*

  2002cited by this paper
• Double-strand breaks and translocations in cancer.

  2002cited by this paper
• Human Genome and Diseases:¶Double-strand breaks and translocations in cancer

  2002cited by this paper
• Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

  2002cited by this paper
• Serum nm23-H1 Protein as a Prognostic Factor in Hematological Malignancies

  2002cited by this paper
• Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.

  2002cited by this paper
• MLL targets SET domain methyltransferase activity to Hox gene promoters.

  2002cited by this paper
• Leukemias related to treatment with DNA topoisomerase II inhibitors.

  2001cited by this paper
• Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

  2001cited by this paper
• Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase

  2000cited by this paper
• The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds

  2000cited by this paper
• Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.

  2000cited by this paper
• Over‐expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL‐60 cells to retinoic acid‐induced differentiation and apoptosis

  2000cited by this paper
• Rapid exchange of histone H1.1 on chromatin in living human cells

  2000cited by this paper
• Nucleophosmin/B23 regulates the susceptibility of human leukemia HL‐60 cells to sodium butyrate‐induced apoptosis and inhibition of telomerase activity

  1999cited by this paper
• MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis.

  1998cited by this paper
• Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.

  1998cited by this paper
• Mining the human proteome: Experience with the human lymphoid protein database

  1998cited by this paper
• High frequency of fusion transcripts of exon 11 and exon 4/5 in AF-4 gene is observed in cord blood, as well as leukemic cells from infant leukemia patients with t(4;11)(q21;q23)

  1998cited by this paper
• Quantitative analysis of Op18 phosphorylation in childhood acute leukemia

  1997cited by this paper
• Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.

  1996cited by this paper
• Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells.

  1995cited by this paper
• Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs.

  1993cited by this paper
• Unusual expression and localization of heat‐shock proteins in human tumor cells

  1992cited by this paper
• Increased expression of the 67kDa-laminin receptor gene in human small cell lung cancer.

  1992cited by this paper
• Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia.

  1991cited by this paper
• Involvement of OP18 in cell proliferation.

  1991cited by this paper
• Quantitation of protein.

  1990cited by this paper
• Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth.

  1989cited by this paper
• Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein.

  1988cited by this paper

• Evolving stratification and biomarker discovery in cancer research with technological advancement of proteomics: 35 years and counting

  2025cites this paper
• Impact of Mammary Tumor Induction on Liver Tissue Proteome.

  2025cites this paper
• Importance of targeted therapies in acute myeloid leukemia

  2021cites this paper
• Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults*

  2017cites this paper
• Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.

  2016cites this paper
• Serum Protein Profiling of Adults and Children With Crohn Disease

  2015cites this paper
• Innovative tools for early detection of cancer

  2014cites this paper
• Quality Control and Ethical Issues of Cancer Biomarker Discovery

  2014cites this paper
• Proteomics Approaches towards Early Detection and Diagnosis of Cancer

  2013cites this paper
• Thermodynamic and structural characterization of the interaction between WD-40 repeat protein 5 (WDR5) and human SET1 family methyltransferases

  2013cites this paper
• Proteomics approaches for myeloid leukemia drug discovery

  2012cites this paper
• Cancer proteomics.

  2012cites this paper
• Liquid Chromatography - Mass Spectrometry for Protein Biomarker Discovery in Pancreatic Adenocarcinoma

  2011cites this paper
• Age-Related Differences in Plasma Proteins: How Plasma Proteins Change from Neonates to Adults

  2011cites this paper
• Biochemistry of the Mixed Lineage Leukemia 1 (MLL1) Protein and Targeted Therapies for Associated Leukemia

  2011cites this paper
• Quantitative proteomics study of breast cancer cell lines isolated from a single patient: Discovery of TIMM17A as a marker for breast cancer

  2010cites this paper
• Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery.

  2010cites this paper
• Multidimensional chromatography coupled to mass spectrometry in analysing complex proteomics samples.

  2010cites this paper
• Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells

  2010cites this paper
• Stable-isotope dilution LC–MS for quantitative biomarker analysis.

  2010cites this paper
• Molecularly Targeted Therapy for Infant ALL

  2010cites this paper
• 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells

  2010cites this paper
• Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides

  2010cites this paper
• Clinical proteomics of myeloid leukemia

  2010cites this paper
• Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion.

  2010cites this paper
• Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines*

  2009cites this paper
• dbDEPC: a database of Differentially Expressed Proteins in human Cancers

  2009cites this paper
• Stable Isotope Dilution Multidimensional Liquid Chromatography-Tandem Mass Spectrometry for Pancreatic Cancer Serum Biomarker Discovery

  2009cites this paper
• Therapeutic targeting of MLL.

  2009cites this paper
• Mass spectrometry-based proteomics reveals distinct mechanisms of astrocyte protein secretion

  2009influential citation
• Selection of pH ranges in 2DE.

  2009cites this paper
• Open Access Research

  2008cites this paper
• Recent Advances in Proteomics and Cancer Biomarker Discovery

  2008cites this paper
• Proteomics in pediatric research and practice.

  2007cites this paper
• Cancer proteomics by quantitative shotgun proteomics

  2007cites this paper